249647-24-3

Basic information

• Product Name: 3-BROMO-4-IODOBENZOIC ACID METHYL ESTER
• Synonyms: 3-BROMO-4-IODOBENZOIC ACID METHYL ESTER;Methyl 3-bromo-4-iodobenzoate;Benzoic acid,3-broMo-4-iodo-, Methyl ester
• CAS NO: 249647-24-3
• Molecular Formula: C₈H₆BrIO₂
• Molecular Weight: 340.94
• Product Categories: Acids & Esters;Bromine Compounds;Iodine Compounds
• Mol File: 249647-24-3.mol
• Article Data: 8

Chemical Properties

• Melting Point: 56-60°C
• Boiling Point: 328.118°C at 760 mmHg
• Flash Point: >110℃
• Appearance: /
• Density: 2.059g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.626
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-BROMO-4-IODOBENZOIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-4-IODOBENZOIC ACID METHYL ESTER(249647-24-3)
• EPA Substance Registry System: 3-BROMO-4-IODOBENZOIC ACID METHYL ESTER(249647-24-3)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 249647-24-3(Hazardous Substances Data)

Usage

General Description

3-Bromo-4-iodobenzoic acid methyl ester is a chemical compound derived from benzoic acid and methyl ester. It is characterized by the presence of bromine and iodine substituents on the benzene ring. 3-BROMO-4-IODOBENZOIC ACID METHYL ESTER is commonly used in organic synthesis and medicinal chemistry as a building block for the creation of complex molecules. It has demonstrated potential applications in pharmaceutical research and drug development, particularly in the synthesis of biologically active compounds. Additionally, it can also be utilized in the production of specialty chemicals and materials. The compound's unique molecular structure and reactivity make it a valuable tool in the development of new chemical entities and compounds.

InChI:InChI=1/C8H6BrIO2/c1-12-8(11)5-2-3-7(10)6(9)4-5/h2-4H,1H3

Upstream product

• 67-56-1 methanol 
• 249647-25-4 3-bromo-4-iodobenzoic acid 
• 6311-37-1 4-amino-3-bromo-benzoic acid 
• 106896-49-5 methyl 4-amino-3-bromobenzoate 
• 619-44-3 methyl 4-iodobenzoate 

Downstream Products

• 249647-25-4 3-bromo-4-iodobenzoic acid 
• 1057977-13-5 4,4'-(1,2-ethynediyl)bis(3-bromobenzoic acid) dimethyl ester 
• 1092491-66-1 C₁₇H₁₅BrO₃ 
• 1033220-95-9 methyl 3-bromo-4-(3-oxopropyl)benzoate 
• 1149684-26-3 methyl 3-bromo-4-(5-oxopentyl)benzoate 
• 1150112-11-0 methyl 3-bromo-4-[(trimethylsilyl)ethynyl]benzoate 
• 1378284-27-5 methyl 3-[(4-methoxyphenyl)ethynyl]-4-[(trimethylsilyl)-ethynyl]benzoate 
• 1383604-50-9 methyl 4-ethynyl-3-(thiophen-2-ylethynyl)benzoate 
• 1401615-53-9 methyl 3-(thiophen-2-ylethynyl)-4-[(trimethylsilyl)ethynyl]benzoate 
• 1383604-51-0 methyl 4-ethynyl-3-(pent-1-ynyl)benzoate 
• 1383604-54-3 dimethyl 2-(4-methoxybenzyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-benzo[g]indazole-1,7-dicarboxylate 
• 1383604-55-4 dimethyl 3-isopropyl-2-(4-methoxybenzyl)-4-(4-methoxyphenyl)-2,3-dihydro-1H-benzo[g]indazole-1,7-dicarboxylate 
• 1383604-56-5 dimethyl 2-(4-methoxybenzyl)-4-(thiophen-2-yl)-2,3-dihydro-1H-benzo[g]indazole-1,7-dicarboxylate 
• 1383604-57-6 dimethyl 3-isopropyl-2-(4-methoxybenzyl)-4-(thiophen-2-yl)-2,3-dihydro-1H-benzo[g]indazole-1,7-dicarboxylate 

Relevant articles and documents

Post synthetic exchange enables orthogonal click chemistry in a metal organic framework

Biphenyl-4,4′-dicarboxylic acid derivatives containing either azide or acetylene functional groups were inserted into UiO-67 metal organic frameworks (MOFs) via post synthetic linker exchange. Sequential and orthogonal click reactions could be performed o

ISOXAZOLINE DERIVATIVES AS ANTIPARASITIC AGENTS

This invention recites isoxazoline substituted azetidine derivatives of Formula (1) stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, and their use as a parasiticide in mammals and birds. R1a, R1b, R1c, R2, R3, R4, R6, and n are as described herein.

BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 065

The invention provides compounds of formula wherein R1, R2, R3, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1